HeartSciences Inc.
HSCS · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Revenue | $4 | $19 | $5 | $14 |
| % Growth | -76.6% | 261.2% | -64.2% | – |
| Cost of Goods Sold | $130 | $101 | $30 | $34 |
| Gross Profit | -$125 | -$83 | -$25 | -$20 |
| % Margin | -2,884.7% | -444.2% | -476.9% | -139.7% |
| R&D Expenses | $4,386 | $2,879 | $2,461 | $3,002 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3,841 | $3,345 | $3,628 | $1,688 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8,227 | $6,223 | $6,088 | $4,689 |
| Operating Income | -$8,353 | -$6,306 | -$6,113 | -$4,709 |
| % Margin | -192,013.1% | -33,902% | -118,698.3% | -32,765.6% |
| Other Income/Exp. Net | -$413 | -$299 | -$241 | -$119 |
| Pre-Tax Income | -$8,765 | -$6,605 | -$6,354 | -$4,828 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,765 | -$6,605 | -$6,354 | -$4,828 |
| % Margin | -201,499.5% | -35,511.9% | -123,384.3% | -33,592.6% |
| EPS | -9.34 | -18.74 | -6,173.88 | -137.94 |
| % Growth | 50.2% | 99.7% | -4,375.8% | – |
| EPS Diluted | -9.34 | -18.74 | -6,173.88 | -137.94 |
| Weighted Avg Shares Out | 938 | 353 | 80 | 33 |
| Weighted Avg Shares Out Dil | 938 | 353 | 80 | 33 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $500 | $354 | $243 | $372 |
| Depreciation & Amortization | $128 | $95 | $27 | $27 |
| EBITDA | -$8,137 | -$6,156 | -$6,084 | -$4,430 |
| % Margin | -187,053.3% | -33,096.7% | -118,139.8% | -30,822.2% |